Cefprozil: Difference between revisions
(Created page with "==Administration== *Type: antibiotic *Dosage Forms: PO *Routes of Administration: PO *Common Trade Names: Cefzil ==Adult Dosing== Infections, bacterial: * 250-500 mg PO q12h...") |
Ostermayer (talk | contribs) (Text replacement - "Category:Drugs" to "Category:Pharmacology") |
||
| Line 53: | Line 53: | ||
==References== | ==References== | ||
<references/> | <references/> | ||
[[Category: | [[Category:Pharmacology]] | ||
Revision as of 15:53, 22 March 2016
Administration
- Type: antibiotic
- Dosage Forms: PO
- Routes of Administration: PO
- Common Trade Names: Cefzil
Adult Dosing
Infections, bacterial:
- 250-500 mg PO q12h x 10 days
Pediatric Dosing
infections, bacterial:
- 30 mg/kg/day PO divided q12h x 10 days, max 1000 mg/day
Special Populations
- Pregnancy Rating: B
- Lactation risk: probably safe
Renal Dosing
- Adult: CrCl < 30: decrease dose 50%
- Pediatric:CrCl < 30: decrease dose 50%
Hepatic Dosing
- Adult: none defined
- Pediatric: none defined
Contraindications
- Allergy to class/drug
- PKU
Adverse Reactions
Serious
- anaphylaxis
- seizures
- nephrotoxicity
- leukopenia or thrombocytopenia
- steven-johnson syndrome
- c-diff associated diarrhea
Common
- nausea
- diarrhea
- vomiting
- transaminitis
- dizziness
- rash
- eosinophilia
Pharmacology
- Half-life: 1.3 h
- Metabolism: other
- Excretion: urine
Mechanism of Action
bactericidal, inhibits cell wall mucopeptide synthesis